CCL22: C-C Motif Chemokine Ligand 22
A key chemokine in immune regulation, inflammation, and cancer
Gene Information Card
| Symbol | CCL22 |
|---|---|
| Full Name | C-C Motif Chemokine Ligand 22 |
| Gene Type | Protein coding |
| Chromosomal Location | 16q13 |
| NCBI Gene ID | 6367 ncbi.nlm.nih.gov/gene/6367 |
| Ensembl ID | ENSG00000102962 |
| UniProt ID | O00626 |
| OMIM ID | 602957 |
| HGNC ID | 10622 |
| Aliases | MDC, STCP-1, ABCD-1, A-152E5.1 |
Description
CCL22 (C-C Motif Chemokine Ligand 22) is a chemokine gene that encodes a small cytokine belonging to the CC chemokine family. The encoded protein, also known as Macrophage-Derived Chemokine (MDC), is secreted by dendritic cells, macrophages, and other immune cells. It binds to the chemokine receptor CCR4, playing a critical role in the recruitment of regulatory T cells (Tregs), Th2 cells, and other leukocytes to sites of inflammation and tumors. CCL22 is involved in immune homeostasis, allergic responses, and cancer immune evasion.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Asthma | CCL22 promotes Th2 cell recruitment via CCR4, contributing to airway inflammation | PMID: 14566332 |
| Atopic dermatitis | Elevated CCL22 levels correlate with disease severity and Treg infiltration | PMID: 16920924 |
| Hodgkin lymphoma | CCL22 expression by Reed-Sternberg cells attracts Tregs, suppressing anti-tumor immunity | PMID: 15692071 |
| Gastric cancer | CCL22 overexpression recruits Tregs, associated with poor prognosis | PMID: 23361059 |
| Ovarian cancer | CCL22 produced by tumor cells and macrophages recruits Tregs, promoting immune escape | PMID: 16204036 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Lymph node | 12.5 | High |
| Spleen | 10.8 | High |
| Appendix | 9.2 | High |
| Lung | 6.1 | Medium |
| Small intestine | 5.4 | Medium |
| Skin | 4.8 | Medium |
| Bone marrow | 3.2 | Low |
| Brain | 0.5 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| THP-1 (monocyte) | 8.7 | High expression after LPS stimulation |
| U937 (macrophage) | 7.2 | High expression after PMA differentiation |
| A549 (lung carcinoma) | 2.1 | Low baseline expression |
| HeLa (cervical carcinoma) | 1.5 | Low expression |
| MCF7 (breast carcinoma) | 0.8 | Not detected |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1Val) | Missense | <0.01% | Likely loss of start codon, reduced protein expression |
| c.274C>T (p.Arg92Cys) | Missense | <0.01% | Unknown functional effect |
| c.346G>A (p.Gly116Ser) | Missense | <0.01% | Unknown functional effect |
Mutation functional classification
Loss of Function (LOF)
No confirmed loss-of-function mutations reported in ClinVar or COSMIC.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported.
Dominant Negative (DN)
No dominant-negative mutations reported.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Chemokine signaling pathway (KEGG: hsa04062)
• Cytokine-cytokine receptor interaction (KEGG: hsa04060)
• T cell receptor signaling pathway (KEGG: hsa04660)
Protein Summary
CCL22 is a 93-amino acid secreted chemokine (precursor 93 aa, mature 69 aa) with a typical CC chemokine structure containing four conserved cysteine residues. It is produced primarily by macrophages, dendritic cells, and certain tumor cells. The protein binds specifically to CCR4, a G protein-coupled receptor expressed on Th2 cells, Tregs, and some cancer cells. CCL22 plays a dual role in immune regulation: it mediates allergic inflammation by recruiting Th2 cells, and it promotes immune evasion in cancer by attracting Tregs into the tumor microenvironment. Elevated CCL22 levels are associated with poor prognosis in several cancers.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CCL22 Knockout HEK293 Cell Line | EDJ-KQ2433 | Human | 6367 | Details Get a Quote |
| CCL22 Knockout HeLa Cell Line | EDJ-KQ54428 | Human | 6367 | Details Get a Quote |
| CCL22 Knockout A-549 Cell Line | EDJ-KQ62916 | Human | 6367 | Details Get a Quote |
| CCL22 Knockout HCT 116 Cell Line | EDJ-KQ71385 | Human | 6367 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records